1. Preliminary comments on proteasome inhibition and cardiovascular disease

   • Friedrich C. Luft

   Clinical Implications 18 June 2009 Pages: 749 - 751

   

2. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation

   • Olaf Hoffmann
   • Frauke Zipp
   • Joerg R. Weber

   Review 17 May 2009 Pages: 753 - 763

   

3. Functions of lipid raft membrane microdomains at the blood–brain barrier

   • Aurore Dodelet-Devillers
   • Romain Cayrol
   • Alexandre Prat

   Review 30 May 2009 Pages: 765 - 774

   

4. Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps

   • Maren von Köckritz-Blickwede
   • Victor Nizet

   Review Open access 16 May 2009 Pages: 775 - 783

   

5. The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy

   • Shin-ichi Oka
   • Tetsuro Ago
   • Junichi Sadoshima

   Review 08 May 2009 Pages: 785 - 791

   

6. Potent anti-inflammatory effects of low-dose proteasome inhibition in the vascular system

   • Antje Ludwig
   • Mandy Fechner
   • Karl Stangl

   Original Article 28 April 2009 Pages: 793 - 802

   

7. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans

   • V. Catalán
   • J. Gómez-Ambrosi
   • G. Frühbeck

   Original Article 23 May 2009 Pages: 803 - 813

   

8. Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity

   • Jasmin Mertens
   • Rusudan Bregadze
   • Sabine Mihm

   Original Article Open access 27 May 2009 Pages: 815 - 824

   

9. OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism

   • Julia Perttilä
   • Krista Merikanto
   • Vesa M. Olkkonen

   Original Article Open access 25 June 2009 Pages: 825 - 835